| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Microbiology and Tumor Biology Center and
Center for Molecular Medicine, Karolinska Institute, and
Department of Virology, Swedish Institute for Infectious Disease Control, Stockholm, Sweden; and
Department of Molecular Biology, Amgen, Seattle, WA 98101
Human CMV (HCMV) interferes with NK cell functions at various levels. The HCMV glycoprotein UL16 binds some of the ligands recognized by the NK-activating receptor NKG2D, namely UL16-binding proteins (ULBP) 1 and 2 and MHC class I-related chain B, possibly representing another mechanism of viral immune escape. This study addressed the expression and function of these proteins in infected cells. HCMV induced the expression of all three ULBPs, which were predominantly localized in the endoplasmic reticulum of infected fibroblasts together with UL16. However, while at a lower viral dose ULBP1 and 2 surface expression was completely inhibited compared to ULBP3, at a higher viral dose cell surface expression of ULBP1 and ULBP2 was delayed. The induction of ULBPs correlated with an increased dependency on NKG2D for recognition; however, the overall NK sensitivity did not change (suggesting that additional viral mechanisms interfere with NKG2D-independent pathways for recognition). Infection with a UL16 deletion mutant virus resulted in a different pattern compared to the wild type: all three ULBP molecules were induced with similar kinetics at the cell surface, accompanied by a pronounced, entirely NKG2D-dependent increase in NK sensitivity. Together our findings show that upon infection with HCMV, the host cell responds by expression of ULBPs and increased susceptibility to the NKG2D-mediated component of NK cell recognition, but UL16 limits these effects by interfering with the surface expression of ULBP1 and ULBP2.
This article has been cited by other articles:
|
|
 |
|
  O. Ashiru, N. J. Bennett, L. H. Boyle, M. Thomas, J. Trowsdale, and M. R. Wills NKG2D Ligand MICA Is Retained in the cis-Golgi Apparatus by Human Cytomegalovirus Protein UL142 J. Virol., December 1, 2009; 83(23): 12345 - 12354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Arapovic, T. Lenac, R. Antulov, B. Polic, Z. Ruzsics, L. N. Carayannopoulos, U. H. Koszinowski, A. Krmpotic, and S. Jonjic Differential Susceptibility of RAE-1 Isoforms to Mouse Cytomegalovirus J. Virol., August 15, 2009; 83(16): 8198 - 8207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cerboni, M. Ardolino, A. Santoni, and A. Zingoni Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells Blood, March 26, 2009; 113(13): 2955 - 2964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kloss, P. Decker, K. M. Baltz, T. Baessler, G. Jung, H.-G. Rammensee, A. Steinle, M. Krusch, and H. R. Salih Interaction of Monocytes with NK Cells upon Toll-Like Receptor-Induced Expression of the NKG2D Ligand MICA J. Immunol., November 15, 2008; 181(10): 6711 - 6719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Walsh, M. B. Lodoen, R. A. Edwards, L. L. Lanier, and T. E. Lane Evidence for Differential Roles for NKG2D Receptor Signaling in Innate Host Defense against Coronavirus-Induced Neurological and Liver Disease J. Virol., March 15, 2008; 82(6): 3021 - 3030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Marusina, S. J. Burgess, I. Pathmanathan, F. Borrego, and J. E. Coligan Regulation of Human DAP10 Gene Expression in NK and T Cells by Ap-1 Transcription Factors J. Immunol., January 1, 2008; 180(1): 409 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ebihara, H. Masuda, T. Akazawa, M. Shingai, H. Kikuta, T. Ariga, M. Matsumoto, and T. Seya Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection Int. Immunol., October 1, 2007; 19(10): 1145 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Cao, X. Xi, Z. Hao, W. Li, Y. Kong, L. Cui, C. Ma, D. Ba, and W. He RAET1E2, a Soluble Isoform of the UL16-binding Protein RAET1E Produced by Tumor Cells, Inhibits NKG2D-mediated NK Cytotoxicity J. Biol. Chem., June 29, 2007; 282(26): 18922 - 18928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Endt, F. E. McCann, C. R. Almeida, D. Urlaub, R. Leung, D. Pende, D. M. Davis, and C. Watzl Inhibitory Receptor Signals Suppress Ligation-Induced Recruitment of NKG2D to GM1-Rich Membrane Domains at the Human NK Cell Immune Synapse J. Immunol., May 1, 2007; 178(9): 5606 - 5611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nedvetzki, S. Sowinski, R. A. Eagle, J. Harris, F. Vely, D. Pende, J. Trowsdale, E. Vivier, S. Gordon, and D. M. Davis Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses Blood, May 1, 2007; 109(9): 3776 - 3785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Prod'homme, C. Griffin, R. J. Aicheler, E. C. Y. Wang, B. P. McSharry, C. R. Rickards, R. J. Stanton, L. K. Borysiewicz, M. Lopez-Botet, G. W. G. Wilkinson, et al. The Human Cytomegalovirus MHC Class I Homolog UL18 Inhibits LIR-1+ but Activates LIR-1- NK Cells J. Immunol., April 1, 2007; 178(7): 4473 - 4481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. McCann, P. Eissmann, B. Onfelt, R. Leung, and D. M. Davis The Activating NKG2D Ligand MHC Class I-Related Chain A Transfers from Target Cells to NK Cells in a Manner That Allows Functional Consequences J. Immunol., March 15, 2007; 178(6): 3418 - 3426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Wagner, G. C. Riise, T. Bergstrom, K. Karre, E. Carbone, and L. Berg Increased Expression of Leukocyte Ig-Like Receptor-1 and Activating Role of UL18 in the Response to Cytomegalovirus Infection J. Immunol., March 15, 2007; 178(6): 3536 - 3543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cerboni, F. Neri, N. Casartelli, A. Zingoni, D. Cosman, P. Rossi, A. Santoni, and M. Doria Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity J. Gen. Virol., January 1, 2007; 88(1): 242 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Spreu, T. Stehle, and A. Steinle Human Cytomegalovirus-Encoded UL16 Discriminates MIC Molecules by Their {alpha}2 Domains. J. Immunol., September 1, 2006; 177(5): 3143 - 3149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Borchers, N. L. Harris, S. C. Wesselkamper, M. Vitucci, and D. Cosman NKG2D ligands are expressed on stressed human airway epithelial cells Am J Physiol Lung Cell Mol Physiol, August 1, 2006; 291(2): L222 - L231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hanaoka, T. Kawaguchi, K. Horikawa, S. Nagakura, H. Mitsuya, and H. Nakakuma Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP Blood, February 1, 2006; 107(3): 1184 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-C. Iversen, P. S. Norris, C. F. Ware, and C. A. Benedict Human NK Cells Inhibit Cytomegalovirus Replication through a Noncytolytic Mechanism Involving Lymphotoxin-Dependent Induction of IFN-{beta} J. Immunol., December 1, 2005; 175(11): 7568 - 7574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Vankayalapati, A. Garg, A. Porgador, D. E. Griffith, P. Klucar, H. Safi, W. M. Girard, D. Cosman, T. Spies, and P. F. Barnes Role of NK Cell-Activating Receptors and Their Ligands in the Lysis of Mononuclear Phagocytes Infected with an Intracellular Bacterium J. Immunol., October 1, 2005; 175(7): 4611 - 4617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Smyth, J. Swann, E. Cretney, N. Zerafa, W. M. Yokoyama, and Y. Hayakawa NKG2D function protects the host from tumor initiation J. Exp. Med., September 6, 2005; 202(5): 583 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Garrity, M. E. Call, J. Feng, and K. W. Wucherpfennig The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure PNAS, May 24, 2005; 102(21): 7641 - 7646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Maasho, J. Opoku-Anane, A. I. Marusina, J. E. Coligan, and F. Borrego Cutting Edge: NKG2D Is a Costimulatory Receptor for Human Naive CD8+ T Cells J. Immunol., April 15, 2005; 174(8): 4480 - 4484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zou, W. Bresnahan, R. T. Taylor, and P. Stastny Effect of Human Cytomegalovirus on Expression of MHC Class I-Related Chains A J. Immunol., March 1, 2005; 174(5): 3098 - 3104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Guma, A. Angulo, C. Vilches, N. Gomez-Lozano, N. Malats, and M. Lopez-Botet Imprint of human cytomegalovirus infection on the NK cell receptor repertoire Blood, December 1, 2004; 104(12): 3664 - 3671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Rosen, M. Araki, J. A. Hamerman, T. Chen, T. Yamamura, and L. L. Lanier A Structural Basis for the Association of DAP12 with Mouse, but Not Human, NKG2D J. Immunol., August 15, 2004; 173(4): 2470 - 2478. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
